Lim, S.Y.; Ferro-López, L.; Barquin, E.; Lindsay, D.; Thway, K.; Smith, M.J.; Benson, C.; Jones, R.L.; Napolitano, A.
Efficacy and Safety of Ripretinib in Advanced Gastrointestinal Stromal Tumors within an Expanded Access Program: A Cohort Study. Cancers 2024, 16, 985.
https://doi.org/10.3390/cancers16050985
AMA Style
Lim SY, Ferro-López L, Barquin E, Lindsay D, Thway K, Smith MJ, Benson C, Jones RL, Napolitano A.
Efficacy and Safety of Ripretinib in Advanced Gastrointestinal Stromal Tumors within an Expanded Access Program: A Cohort Study. Cancers. 2024; 16(5):985.
https://doi.org/10.3390/cancers16050985
Chicago/Turabian Style
Lim, Su Yin, Laura Ferro-López, Elizabeth Barquin, Daniel Lindsay, Khin Thway, Myles J. Smith, Charlotte Benson, Robin L. Jones, and Andrea Napolitano.
2024. "Efficacy and Safety of Ripretinib in Advanced Gastrointestinal Stromal Tumors within an Expanded Access Program: A Cohort Study" Cancers 16, no. 5: 985.
https://doi.org/10.3390/cancers16050985
APA Style
Lim, S. Y., Ferro-López, L., Barquin, E., Lindsay, D., Thway, K., Smith, M. J., Benson, C., Jones, R. L., & Napolitano, A.
(2024). Efficacy and Safety of Ripretinib in Advanced Gastrointestinal Stromal Tumors within an Expanded Access Program: A Cohort Study. Cancers, 16(5), 985.
https://doi.org/10.3390/cancers16050985